Nestle buys Pfizer’s nutrition business

Nestle has completed the purchase of Pfizer’s nutrition business for $11.85bn in cash, following the conclusion of the regulatory process in most markets.
Comprising of brands and product portfolio, Pfizer’s nutrition business complements Nestle’s infant nutrition business.  Pharmaceutical Business Review – Read more…